Aripiprazole-induced oculogyric crisis (acute dystonia)

Journal of Pharmacology and Pharmacotherapeutics

Volumn 3, Issue 3, 2012, Pages 279-281

  Bhachech, Jyotik T ^a  

^a Santvan Hospital   (India)

Author keywords

Aripiprazole; oculogyric crisis; promethazine

Indexed keywords

ARIPIPRAZOLE; ESZOPICLONE; PROMETHAZINE; ZIPRASIDONE;

ADULT; ARTICLE; AUDITORY HALLUCINATION; BEDTIME DOSAGE; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; CONVALESCENCE; DISEASE ASSOCIATION; DISEASE DURATION; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG SAFETY; DRUG WITHDRAWAL; EVENING DOSAGE; FEMALE; FOLLOW UP; HUMAN; IRRITABILITY; OCULOGYRIC CRISIS; PARANOID SCHIZOPHRENIA; PRESCRIPTION; PSYCHOLOGIC ASSESSMENT; TREATMENT DURATION;

EID: 84865054228     PISSN: 0976500X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0976-500X.99446     Document Type: Article

References (20)

1. Stahl SM. Dopamine system stabilizers, Aripiprazole and next generation antipsychotics part 1, "Goldilocks" action at dopamine receptors. J Clin Psychiatry 2001;62:841-2. (Pubitemid 33131168)
2. Burris KD, Molski TF, Xu C, Ryan E, Tottori K, Kikuchi T, et al. Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors. J Pharmacol Exp Ther 2002;302:381-9. (Pubitemid 34680462)
3. Ozdemir V, Fourie J, Ozdener F. Aripi-prazole (Otsuka Pharmaceutical Co). Curr Opin Investig Drugs 2002;3:113-20.
4. Sarin A, Nagpal J, Bohra NK, Jiloha RC, Rao GP, Sharma SK, et al. Open labeled, randomized, switch over study of two fixed doses (10/15 mg) of aripiprazole: To evaluate its safety and efficacy in Indian patients of schizophrenia. Indian J Psychiatry 2004;46:64-71. (Pubitemid 39073395)
5. Rich SS. Drug induced movement disorders. Rhode Island Med 1993;76:556-62.
6. American Psychiatric Association Diagnostic and Statistical Manual of mental disorders. 4th ed. Washington DC: American Psychiatric Association; 2000.
7. N van Harten P, Hoek HW, Kahn RS. Acute dystonia induced by drug treatment. BMJ 1999;319:623-6. (Pubitemid 29414563)
8. Sanghadia M, Pinninti NR. Aripiprazole associated acute dystonia. J Neuropsychiatry Clin Neurosci 2007;19:89-90.
9. Desarkar P, Thakur A, Sinha VK. Aripiprazole induced acute dystonia. Am J Psychiatry 2006;163:1112-3.
10. Zacher JL, Hatchett AD. Aripiprazole induced movement disorder. Am J Psychiatry 2006;163:160-1.
11. Fajolu IB, Lesi FE. Drug-induced acute dystonia in a 7 year old child following the use of artesunate-amodiaquine: A case report. Int J Risk Saf Med 2010;22:111-4.
12. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45. (Pubitemid 12149145)
13. Holloway K, Green T. Drug and therapeutics committees: A practical guide. Geneva: World Health Organization; 2003. p. 62-70.
14. Sethi KD. Movement disorders induced by dopamine blocking agents. Semin Neurol 2001;21:59-68. (Pubitemid 32382031)
15. Mendhekar DN. Recurrent oculogyric crisis and retrocollis after re exposure with a low dose of olanzapine. Indian J Pharmocol 2005;37:337. (Pubitemid 41434096)
16. Madhusoodanan S, Alexeenko L, Sanders R, Brenner R. Extrapyramidal symptoms associated with antidepressants-A review of the literature and an analysis of spontaneous reports. Ann Clin Psychiatry 2010;22:148-56.
17. Ncecik A, Metoclopramide induced acute dystonic reaction: Two case reports. Marmara Med J 2008;21:159-61.
18. Sharma DD, Aggarwal A, Sharma RC, Kumar R. A Probable association of acute dystonia with gemifloxacin administration. Indian J Med Sci 2009;63:557-60.
19. Fadare JO, Owolabi LF. Carbamazepine-induced dystonia: A case report. Neurol Asia 2009;14:165-6.
20. Stolarek IH, Ford MJ. Acute dystonia induced by midazolam and abolished by flumazenil. BMJ 1990;300:614. (Pubitemid 20090313)